| Schedule of EPS amounts for all periods and the basic and diluted weighted-average shares outstanding used in the calculation |
| | | | | | | | | | | | | | | For the Three Months Ended | | For the Six Months Ended | | | June 30, | | June 30, | | | 2024 | | 2023 | | 2024 | | 2023 | | | | (In thousands, except per share amounts) | Net income (loss) | | $ | (207,458) | | $ | 232,692 | | $ | (315,833) | | $ | 505,537 | Less: Net income (loss) attributable to noncontrolling interests, net of tax | | | (1,867) | | | 20,030 | | | (2,866) | | | 39,341 | Net income (loss) attributable to EchoStar - Basic | | | (205,591) | | | 212,662 | | | (312,967) | | | 466,196 | Interest on dilutive Convertible Notes, net of tax (1) (3) | | | — | | | — | | | — | | | — | Net income (loss) attributable to EchoStar - Diluted | | $ | (205,591) | | $ | 212,662 | | $ | (312,967) | | $ | 466,196 | | | | | | | | | | | | | | Weighted-average common shares outstanding - Class A and B common stock: | | | | | | | | | | | | | Basic | | | 271,592 | | | 270,818 | | | 271,555 | | | 270,328 | Dilutive impact of Convertible Notes (2)(3) | | | — | | | 37,550 | | | — | | | 37,550 | Dilutive impact of stock awards outstanding (3) | | | — | | | 7 | | | — | | | 70 | Diluted | | | 271,592 | | | 308,375 | | | 271,555 | | | 307,948 | | | | | | | | | | | | | | Earnings per share - Class A and B common stock: | | | | | | | | | | | | | Basic net income (loss) per share attributable to EchoStar | | $ | (0.76) | | $ | 0.79 | | $ | (1.15) | | $ | 1.72 | Diluted net income (loss) per share attributable to EchoStar | | $ | (0.76) | | $ | 0.69 | | $ | (1.15) | | $ | 1.51 |
| (1) | For both the three and six months ended June 30, 2023, substantially all of our interest expense was capitalized. See Note 2 for further information. |
| (2) | We repurchased or redeemed the principal balance of our 2 3/8% Convertible Notes due 2024 as of March 15, 2024, the instrument’s maturity date. |
| (3) | For the three and six months ended June 30, 2024, the dilutive impact of 33 million and 35 million weighted-average shares of Class A common stock, respectively, were excluded from the computation of “Diluted net income (loss) per share attributable to EchoStar” because the effect would have been anti-dilutive as a result of the net loss attributable to EchoStar in the period. |
|
| Schedule of anti-dilutive securities not included in the diluted EPS calculation |
| | | | | | | As of June 30, | | | 2024 | | 2023 | | | | (In thousands) | Anti-dilutive stock awards | | 9,762 | | 11,241 | Performance/market based options | | 4,421 | | 4,861 | Restricted Performance Units/Awards | | — | | — | Common stock warrants | | 16,151 | | 16,151 | Total | | 30,334 | | 32,253 |
|